BML, Inc. (TYO:4694)
2,900.00
+41.00 (1.43%)
May 12, 2025, 3:30 PM JST
BML, Inc. Revenue
In the fiscal year ending March 31, 2025, BML, Inc. had annual revenue of 143.19B JPY with 3.79% growth. BML, Inc. had revenue of 34.61B in the quarter ending March 31, 2025, with 5.69% growth.
Revenue
143.19B
Revenue Growth
+3.79%
P/S Ratio
0.79
Revenue / Employee
31.73M
Employees
4,513
Market Cap
112.92B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 143.19B | 5.23B | 3.79% |
Mar 31, 2024 | 137.96B | -21.50B | -13.48% |
Mar 31, 2023 | 159.46B | -26.61B | -14.30% |
Mar 31, 2022 | 186.07B | 47.50B | 34.28% |
Mar 31, 2021 | 138.57B | 17.84B | 14.78% |
Mar 31, 2020 | Pro | Pro | Pro |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,222.12B |
Takeda Pharmaceutical Company | 4,581.55B |
Daiichi Sankyo Company | 1,886.26B |
HOYA Corporation | 869.37B |
Terumo | 1,011.15B |
Otsuka Holdings | 2,393.18B |
Astellas Pharma | 1,912.32B |
Olympus | 993.33B |